- Drug Pipelines
- March 2021
Global
From €1919EUR$2,000USD£1,659GBP
- Drug Pipelines
- March 2021
Global
From €1919EUR$2,000USD£1,659GBP
- Drug Pipelines
- October 2020
- 131 Pages
Global
From €1919EUR$2,000USD£1,659GBP
- Drug Pipelines
- October 2020
- 104 Pages
Global
From €1919EUR$2,000USD£1,659GBP
- Report
- December 2022
- 35 Pages
Global
From €1919EUR$2,000USD£1,659GBP
- Report
- December 2022
- 37 Pages
Global
From €1919EUR$2,000USD£1,659GBP
- Report
- April 2022
- 207 Pages
Global
From €1919EUR$2,000USD£1,659GBP
- Report
- April 2021
- 30 Pages
Global
From €1919EUR$2,000USD£1,659GBP
- Report
- April 2021
- 40 Pages
Global
From €1919EUR$2,000USD£1,659GBP
- Report
- April 2021
- 50 Pages
Global
From €1919EUR$2,000USD£1,659GBP
- Report
- April 2021
- 40 Pages
Global
From €1919EUR$2,000USD£1,659GBP
- Drug Pipelines
- June 2020
- 42 Pages
Global
From €1919EUR$2,000USD£1,659GBP
- Report
- May 2022
- 40 Pages
Poland
From €2490EUR$2,595USD£2,153GBP
From €2490EUR$2,595USD£2,153GBP
- Report
- May 2022
- 40 Pages
United Kingdom
From €2490EUR$2,595USD£2,153GBP
- Report
- May 2022
- 40 Pages
Vietnam
From €2490EUR$2,595USD£2,153GBP
- Report
- May 2022
- 40 Pages
United States
From €2490EUR$2,595USD£2,153GBP
- Report
- May 2022
- 40 Pages
South Korea
From €2490EUR$2,595USD£2,153GBP
- Report
- May 2022
- 40 Pages
Russia
From €2490EUR$2,595USD£2,153GBP
- Report
- May 2022
- 40 Pages
Japan
From €2490EUR$2,595USD£2,153GBP
The Metabolic Disorder Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. It includes drugs used to treat metabolic disorders such as diabetes, obesity, and hyperlipidemia. These drugs are used to regulate the body's metabolism, which is the process of converting food into energy. Common drugs used to treat metabolic disorders include insulin, sulfonylureas, biguanides, thiazolidinediones, and GLP-1 agonists. These drugs are used to control blood sugar levels, reduce cholesterol, and promote weight loss.
The Metabolic Disorder Drug market is highly competitive, with many companies offering a variety of drugs to treat metabolic disorders. Some of the major players in the market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. Other companies in the market include Boehringer Ingelheim, Takeda, and Pfizer. Show Less Read more